The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans
Abstract
Glycosaminoglycan (GAG) binding proteins (GAGBPs), including growth factors, cytokines, morphogens, and extracellular matrix proteins, interact with both free GAGs and those covalently linked to proteoglycans. Such interactions modulate a variety of cellular and extracellular events, such as cell growth, metastasis, morphogenesis, neural development, and inflammation. GAGBPs are structurally and evolutionarily unrelated proteins that typically recognize internal sequences of sulfated GAGs. GAGBPs are distinct from the other major group of glycan binding proteins, lectins. The multifunctional human galectin-3 (Gal-3) is a β-galactoside binding lectin that preferentially binds to N-acetyllactosamine moieties on glycoconjugates. Here, we demonstrate through microcalorimetric and spectroscopic data that Gal-3 possesses the characteristics of a GAGBP. Gal-3 interacts with unmodified heparin, chondroitin sulfate-A (CSA), -B (CSB), and -C (CSC) as well as chondroitin sulfate proteoglycans (CSPGs). While heparin, CSA, and CSC bind with micromolar affinity, the affinity of CSPGs is nanomolar. Significantly, CSA, CSC, and a bovine CSPG were engaged in multivalent binding with Gal-3 and formed noncovalent cross-linked complexes with the lectin. Binding of sulfated GAGs was completely abolished when Gal-3 was preincubated with β-lactose. Cross-linking of Gal-3 by CSA, CSC, and the bovine CSPG was reversed by β-lactose. Both observations strongly suggest that GAGs primarily occupy the lactose/LacNAc binding site of Gal-3. Hill plot analysis of calorimetric data reveals that the binding of CSA, CSC, and a bovine CSPG to Gal-3 is associated with progressive negative cooperativity effects. Identification of Gal-3 as a GAGBP should help to reveal new functions of Gal-3 mediated by GAGs and proteoglycans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,089
Glycosaminoglycans and Their Binding to Biological Macromolecules
Lindahl, U., & Höök, M. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.002125 · Cited by 835
Demystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K., Sweeney, M., & Proudfoot, A. E. I. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161747 · Cited by 531
X-ray Crystal Structure of the Human Galectin-3 Carbohydrate Recognition Domain at 2.1-Å Resolution
Seetharaman, J., Kanigsberg, A. I., Slaaby, R., Leffler, H., Barondes, S. H., & Rini, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13047 · Cited by 442
Galectin-3 – A jack-of-all-trades in cancer
Newlaczyl, A. U., & Yu, L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.003 · Cited by 363
Glycosylation in immune cell trafficking
Sperandio, M., Gleissner, C. A., & Ley, K. F. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00795.x · Cited by 321
GLYCOMICS APPROACH TO STRUCTURE-FUNCTION RELATIONSHIPS OF GLYCOSAMINOGLYCANS
Sasisekharan, R., Raman, R., & Prabhakar, V. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095745 · Cited by 296
Structural view of glycosaminoglycan–protein interactions
Imberty, A., Lortat‐Jacob, H., & Pérez, S. (2006) · Carbohydrate Research · doi:10.1016/j.carres.2006.12.019 · Cited by 224
Effects of Clustered Epitopes in Multivalent Ligand−Receptor Interactions
Dam, T. K., & Brewer, C. F. (2008) · Biochemistry · doi:10.1021/bi801208b · Cited by 190
Self-citation
Flagged first, then by citations
Research works printed but not linked: 4
- Esko J. D., 2009, Essentials of Glycobiology
- Cummings R. D., 2009, Essentials of Glycobiology
- Cummings R. D., 2009, Essentials of Glycobiology
- Varki A., 2009, Essentials of Glycobiology
Cited by
Sorted by citations
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Recently it has even been shown that some galectins bind efficiently to as yet undefined motifs on bacterial surfaces (777) as well as to some sulfated glycosaminoglycans (1062), in a manner still inhibitable by its canonical ligand lactose.”
BackgroundGalectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., Francesco, G. P. D., Bellotti, C., Salehi, L. B., & Rícci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 387
Suthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0343-y · Cited by 307
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Suthahar, N., Meijers, W. C., Silljé, H. H. W., Ho, J. E., Liu, F., & de Boer, R. A. (2017) · Theranostics · doi:10.7150/thno.22196 · Cited by 309
Galectin-3 in Cardiovascular Diseases
Blanda, V., Bracale, U. M., Taranto, M. D. D., & Fortunato, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239232 · Cited by 212
Metadata
- Authors
- Talaga, M. L., Fan, N., Fueri, A. L., Brown, R. K., Bandyopadhyay, P., & Dam, T. K.
- Affiliations
- Michigan Technological University (US)
- Corresponding author
- Dam, Tarun K.
- ORCID
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-08-02
- Volume
- 55
- Issue
- 32
- Pages
- 4541-4551
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2504287313
- Cited by
- 44
- References
- 40
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 1
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - Michigan Tech (Michigan Technological University) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- galectin-3, glycosaminoglycan-binding proteins, sulfated glycosaminoglycans, chondroitin sulfate proteoglycans, heparin, multivalent binding, non-covalent crosslinking, beta-lactose, negative cooperativity, binding affinity, lectin-glycan interactions
- MeSH terms
- Amino Sugars, Animals, Binding Sites, Cattle, Dermatan Sulfate, Dose-Response Relationship, Drug, Glycosaminoglycans, Heparin, Humans, Hydrogen-Ion Concentration, Lactose, Protein Binding, Chondroitin Sulfate Proteoglycans, Sodium Chloride, Galectin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review